Literature DB >> 25532380

[Preliminary study on integration of traditional Chinese medicine and western medicine in patients with coronary heart disease in real world].

Gui-Hua Li, Hong-Yan Jiang, Yan-Ming Xie, Qing-Hua Ai, Wei Zhao.   

Abstract

OBJECTIVE: Observe and analyze the informations of western medicine and traditional Chinese medicine in patients with coronary heart disease (CHD), in order to provide reference for clinical treatment.
METHOD: Select patients with CHD in diagnosis of the first place in 17 hospitals, drug informations of these patients were analyzed using frequency method and association rules. RESULT: In 84 697 patients,there were 47 564 males and 32 882 females. The median age was 71 years old, 76 172 patients have medicine records, including 278 kinds of western medicine and 331 kinds of traditional Chinese medicine. Aspirin was the most common used western medicine (51 132 patients, 67.08%), followed by isosorbide dinitrate, clopidogrel etc. The most common used traditional Chinese medicine was danhong injection, followed by shuxuetong injection. After classified the drugs, at the forefront of western medicine were antiplatelet drugs, nitrates drugs, statins, beta blockers, calcium antagonists, ACEI; the most used in traditional Chinese medicine was injection of blood-activating and stasis-resolving, followed by oral preparations of blood-activating and stasis-resolving medicine, Fuzheng class oral medicine, purgation medicine etc. After association rules, combination therapy among western medicine was the most common, combination of western medicine with blood-activating and stasis-resolving was very commonly, especially antiplatelet drugs and nitrates drugs.
CONCLUSION: Western medicine in the treatment of patients with CHD was in accordance with the guidelines recommend, but with the lower utilization rate. Traditional Chinese medicine has become an important method for the treatment of CHD, promoting blood circulation and removing blood stasis is an important part of traditional Chinese medicine treatment in patients with CHD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25532380

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Application of Feedback System Control Optimization Technique in Combined Use of Dual Antiplatelet Therapy and Herbal Medicines.

Authors:  Wang Liu; Yu-Long Li; Mu-Ting Feng; Yu-Wei Zhao; Xianting Ding; Ben He; Xuan Liu
Journal:  Front Physiol       Date:  2018-05-04       Impact factor: 4.566

2.  Rapid bioluminescence assay for monitoring rat CES1 activity and its alteration by traditional Chinese medicines.

Authors:  Jun Zhang; Dandan Wang; Liwei Zou; Min Xiao; Yufeng Zhang; Ziwei Li; Ling Yang; Guangbo Ge; Zhong Zuo
Journal:  J Pharm Anal       Date:  2020-05-21

3.  Clinical Study for Safety Evaluation of GXN Tablets Combined with Aspirin in Long-Term Treatment of Coronary Heart Disease.

Authors:  Mingjie Zi; Ruiqi Li; Fang Lu; Qingna Li; Yang Zhao; Huijuan Jia; Mingyue Sun; Qiaoning Yang; Panbo Qiu; Eryang Wei; Shuge Wang; Rui Li; Wantong Zhang; Weiyi Cao; Yanling Li; Hao Xu; Rui Gao
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-07       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.